JP2007507443A5 - - Google Patents

Download PDF

Info

Publication number
JP2007507443A5
JP2007507443A5 JP2006530007A JP2006530007A JP2007507443A5 JP 2007507443 A5 JP2007507443 A5 JP 2007507443A5 JP 2006530007 A JP2006530007 A JP 2006530007A JP 2006530007 A JP2006530007 A JP 2006530007A JP 2007507443 A5 JP2007507443 A5 JP 2007507443A5
Authority
JP
Japan
Prior art keywords
acid
salts
addition salts
converted
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006530007A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007507443A (ja
Filing date
Publication date
Priority claimed from ES200302275A external-priority patent/ES2229928B1/es
Application filed filed Critical
Publication of JP2007507443A publication Critical patent/JP2007507443A/ja
Publication of JP2007507443A5 publication Critical patent/JP2007507443A5/ja
Pending legal-status Critical Current

Links

JP2006530007A 2003-10-02 2004-09-22 ピリミジン−2−アミン誘導体およびa2bアデノシン受容体アンタゴニストとしてのその使用 Pending JP2007507443A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200302275A ES2229928B1 (es) 2003-10-02 2003-10-02 Nuevos derivados de pirimidin-2-amina.
PCT/EP2004/010644 WO2005040155A1 (en) 2003-10-02 2004-09-22 Pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists

Publications (2)

Publication Number Publication Date
JP2007507443A JP2007507443A (ja) 2007-03-29
JP2007507443A5 true JP2007507443A5 (cg-RX-API-DMAC7.html) 2007-10-11

Family

ID=34507890

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006530007A Pending JP2007507443A (ja) 2003-10-02 2004-09-22 ピリミジン−2−アミン誘導体およびa2bアデノシン受容体アンタゴニストとしてのその使用

Country Status (24)

Country Link
US (1) US20070265273A1 (cg-RX-API-DMAC7.html)
EP (1) EP1668000A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007507443A (cg-RX-API-DMAC7.html)
KR (1) KR20060097010A (cg-RX-API-DMAC7.html)
CN (1) CN1886402A (cg-RX-API-DMAC7.html)
AR (1) AR046170A1 (cg-RX-API-DMAC7.html)
AU (1) AU2004283800B8 (cg-RX-API-DMAC7.html)
BR (1) BRPI0415324A (cg-RX-API-DMAC7.html)
CA (1) CA2540765A1 (cg-RX-API-DMAC7.html)
CO (1) CO5690593A2 (cg-RX-API-DMAC7.html)
EC (1) ECSP066426A (cg-RX-API-DMAC7.html)
ES (1) ES2229928B1 (cg-RX-API-DMAC7.html)
IL (1) IL174771A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06003525A (cg-RX-API-DMAC7.html)
NO (1) NO20061952L (cg-RX-API-DMAC7.html)
NZ (1) NZ546266A (cg-RX-API-DMAC7.html)
PE (1) PE20050473A1 (cg-RX-API-DMAC7.html)
RU (1) RU2006114746A (cg-RX-API-DMAC7.html)
SG (1) SG149077A1 (cg-RX-API-DMAC7.html)
TW (1) TW200526645A (cg-RX-API-DMAC7.html)
UA (1) UA82563C2 (cg-RX-API-DMAC7.html)
UY (1) UY28529A1 (cg-RX-API-DMAC7.html)
WO (1) WO2005040155A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200602139B (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101039677A (zh) 2004-10-15 2007-09-19 Cv医药有限公司 利用a2b腺苷受体拮抗剂预防和治疗气道重建及肺部炎症的方法
ES2270715B1 (es) * 2005-07-29 2008-04-01 Laboratorios Almirall S.A. Nuevos derivados de pirazina.
ES2274712B1 (es) 2005-10-06 2008-03-01 Laboratorios Almirall S.A. Nuevos derivados imidazopiridina.
DE102006046410A1 (de) * 2006-09-20 2008-03-27 Eberhard-Karls-Universität Tübingen Universitätsklinikum Arzneimittel zur Prophylaxe oder Behandlung oder Diagnostik von ischämischen Krankheiten
ES2303776B1 (es) * 2006-12-29 2009-08-07 Laboratorios Almirall S.A. Derivados de 5-fenil-6-piridin-4-il-1,3-dihidro-2h-imidazo(4,5-b)piridin-2-ona utiles como antagonistas del receptor de adenosina a2b.
ES2320955B1 (es) 2007-03-02 2010-03-16 Laboratorios Almirall S.A. Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
KR20100020454A (ko) * 2007-06-08 2010-02-22 바이엘 크롭사이언스 소시에떼아노님 살진균제 헤테로사이클릴-피리미디닐-아미노 유도체
KR20100025006A (ko) * 2007-07-26 2010-03-08 노파르티스 아게 염증성 또는 알레르기성 질병의 치료에 유용한 피리미딘 유도체
WO2009026276A1 (en) 2007-08-22 2009-02-26 Irm Llc 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
CA2697077C (en) * 2007-08-22 2012-10-16 Irm Llc 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
EP2108641A1 (en) 2008-04-11 2009-10-14 Laboratorios Almirall, S.A. New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en) 2008-04-28 2009-11-04 Laboratorios Almirall, S.A. New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
EP2308866A1 (de) 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
EP2322176A1 (en) 2009-11-11 2011-05-18 Almirall, S.A. New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
WO2011076725A1 (en) 2009-12-21 2011-06-30 Bayer Cropscience Ag Thienylpyri (mi) dinylazole and their use for controlling phytopathogenic fungi
KR101993867B1 (ko) * 2010-02-05 2019-06-27 헵테얼즈 테라퓨틱스 리미티드 1,2,4-트리아진-4-아민 유도체들
MX2013007336A (es) 2010-12-21 2013-08-01 Novartis Ag Compuestos de bi-heteroarilo como inhibidores de vps34.
AU2020205753B2 (en) 2019-01-11 2025-05-29 Omeros Corporation Methods and compositions for treating cancer
CN112625050B (zh) 2019-07-30 2021-10-01 杭州阿诺生物医药科技有限公司 一种a2a和/或a2b受体抑制剂的制备方法
CN112028891B (zh) 2019-07-30 2022-07-05 厦门宝太生物科技股份有限公司 腺苷受体拮抗剂
CN115477653B (zh) * 2022-10-11 2024-04-09 安徽省庆云医药股份有限公司 一种曲拉西利关键中间体及曲拉西利的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US22106A (en) * 1858-11-23 Truss-bridge
US275038A (en) * 1883-04-03 Ors to themselves
US42891A (en) * 1864-05-24 Improvement in water-engines
US23763A (en) * 1859-04-26 Method of adjusting the knives of rotary cutter-heads for planing wood
US176399A (en) * 1876-04-18 Improvement in boxes for packing crackers
GB9309573D0 (en) * 1993-05-10 1993-06-23 Merck Sharp & Dohme Therapeutic agents
US5686470A (en) * 1995-02-10 1997-11-11 Weier; Richard M. 2, 3-substituted pyridines for the treatment of inflammation
US7189717B2 (en) * 2000-04-26 2007-03-13 Eisai Co., Ltd. Medicinal compositions promoting bowel movement
US6641549B2 (en) * 2001-02-05 2003-11-04 Bsn Medical, Inc. Custom-moldable support for patellar tendinitis
TWI330183B (cg-RX-API-DMAC7.html) * 2001-10-22 2010-09-11 Eisai R&D Man Co Ltd
WO2003057689A1 (en) * 2002-01-02 2003-07-17 Fujisawa Pharmaceutical Co., Ltd. Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them

Similar Documents

Publication Publication Date Title
JP2007507443A5 (cg-RX-API-DMAC7.html)
HRP20110425T4 (hr) Postupak za pripremu oksikodon hidroklorida koji ima manje od 25 ppm 14-hidroksikodeinona
ZA200710145B (en) Method for the production of 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl-benzofuran-2-carboxamide
NO20063748L (no) Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer
JP2006526031A5 (cg-RX-API-DMAC7.html)
MX2009004900A (es) Arilamidas sustituidas por tiazol u oxazol.
CY1113029T1 (el) Παραγωγα αζαδικυκλο [3.1.0] εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
ATE545413T1 (de) Antagonisten des opioidrezeptors
TW200738716A (en) Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
MY141194A (en) Process for the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts
NO20074055L (no) Prosesser for a fremstille 4-(fenoksy-5-metylpyrimidin-4-yloksy)piperidin-1-karboksylsyrederivater og relaterte forbindelser
HRP20130614T1 (en) Novel pyrazole-substituted arylamides
WO2009156864A3 (en) Substituted alkyl pyrimidin-4-one derivatives
CN103709120B (zh) 一种盐酸阿考替胺三水合物的制备方法
TNSN05140A1 (en) Perindopril
PT1828177E (pt) Novos antagonistas dos receptores da mch
NO20063597L (no) Acetylinske piperazinforbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20090332L (no) 4-amino-3-arylamino-6-arylpyrazol[3,4-D]pyrimidinderivater, fremgangsmater for deres fremstilling og dere anvendelse som antivirale midler
WO2006070349A3 (en) Novel process for preparing pramipexole and its optical isomeric mixture by reduction with sodium triacetoxyborohydride
IL200323A0 (en) Synthesis of glyt-1 inhibitors
WO2006103696A3 (en) Process for preparing levetiracetam and racemization of (r)- and (s)-2-amino butynamide and the corresponding acid derivatives
WO2006126035A3 (en) Process for the preparation of rosuvastatin
ATE525371T1 (de) Salze von imidazol-5-carbonsäure-derivaten, herstellungsverfahren und verwendung davon
EA200700364A1 (ru) Производные амида кинуреновой кислоты как антагонисты nr2b подтипа рецептора nmda
MXPA05003695A (es) Nuevo proceso para la sintesis de compuestos de 1,3-dihidro-2h-3-benzazepin-2-ona, y aplicacion en la sintesis de ivabradina y sales de adicion de la misma con un acido farmaceuticamente aceptable.